Insights into the pathogenesis of psoriatic arthritis from genetic studies.
Sara RahmatiQuan LiProton RahmanVinod ChandranPublished in: Seminars in immunopathology (2021)
Psoriatic arthritis (PsA) is a relatively common inflammatory arthritis, a spondyloarthritis (SpA), that occurs most often in patients with psoriasis, a common immune-mediated inflammatory skin disease. Both psoriasis and PsA are highly heritable. Genetic and recent genomic studies have identified variants associated with psoriasis and PsA, but variants differentiating psoriasis from PsA are few. In this review, we describe recent developments in understanding the genetic burden of PsA, linkage, association and epigenetic studies. Using pathway analysis, we provide further insights into the similarities and differences between PsA and psoriasis, as well as between PsA and other immune-mediated inflammatory diseases, particularly ankylosing spondylitis, another SpA. Environmental factors that may trigger PsA in patients with psoriasis are also reviewed. To further understand the pathogenetic differences between PsA and psoriasis as well as other SpA, larger cohort studies of well-phenotyped subjects with integrated analysis of genomic, epigenomic, transcriptomic, proteomic and metabolomic data using interomic system biology approaches are required.
Keyphrases
- prostate cancer
- radical prostatectomy
- copy number
- ankylosing spondylitis
- genome wide
- rheumatoid arthritis
- atopic dermatitis
- oxidative stress
- dna methylation
- gene expression
- disease activity
- magnetic resonance imaging
- case control
- machine learning
- risk factors
- electronic health record
- big data
- data analysis
- soft tissue